Recurrent vulvovaginitis

Anna M Powell; Paul Nyirjesy

doi:10.1016/j.bpobgyn.2014.07.006

Recurrent vulvovaginitis

Best Pract Res Clin Obstet Gynaecol. 2014 Oct;28(7):967-76. doi: 10.1016/j.bpobgyn.2014.07.006. Epub 2014 Jul 17.

Authors

Anna M Powell¹, Paul Nyirjesy²

Affiliations

¹ Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC, USA; Department of Obstetrics and Gynecology and Medicine, Drexel Vaginitis Center, Drexel University College of Medicine, Philadelphia, PA, USA. Electronic address: powell.am@gmail.com.
² Department of Obstetrics and Gynecology and Medicine, Drexel Vaginitis Center, Drexel University College of Medicine, Philadelphia, PA, USA.

PMID: 25220102
DOI: 10.1016/j.bpobgyn.2014.07.006

Abstract

Vulvovaginitis (VV) is one of the most commonly encountered problems by a gynecologist. Many women frequently self-treat with over-the-counter medications, and may present to their health-care provider after a treatment failure. Vulvovaginal candidiasis, bacterial vaginosis, and trichomoniasis may occur as discreet or recurrent episodes, and have been associated with significant treatment cost and morbidity. We present an update on diagnostic capabilities and treatment modalities that address recurrent and refractory episodes of VV.

Keywords: bacterial vaginosis; trichomoniasis; vaginitis; vulvaginal candidiasis.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Candidiasis, Vulvovaginal / diagnosis
Candidiasis, Vulvovaginal / drug therapy
Candidiasis, Vulvovaginal / etiology
Female
Humans
Recurrence
Trichomonas Vaginitis / diagnosis
Trichomonas Vaginitis / drug therapy
Trichomonas Vaginitis / etiology
Vaginosis, Bacterial / diagnosis
Vaginosis, Bacterial / drug therapy
Vaginosis, Bacterial / etiology
Vulvovaginitis / diagnosis*
Vulvovaginitis / drug therapy
Vulvovaginitis / etiology